This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

REGINALD A. HIGGONS, M.D.; CLARA NIGG, Ph.D.; GERTRUDE M. HYDE, M.D.; CHARLES H. MANN, M.D.

Am J Dis Child. 1948;75(6):887-899.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN SELECTING the kind of influenza virus vaccine to be used in the immunization of children, it appeared necessary that consideration be given the advantages and disadvantages, if any, of the various kinds of vaccine available.

At the time this study was undertaken there were four kinds of influenza virus vaccine which had been recommended for clinical use. All were prepared from the allantoic fluid of chick embryos infected with influenza virus, and all contained 50 per cent type A (half PR₈ strain and half Weiss strain) and 50 per cent type B (Lee strain) viruses. Both types were included because they do not cross immunize. These four kinds of vaccine differed in the way the allantoic fluid was processed, as follows:

One kind of vaccine, commonly called the eluate vaccine,¹ was prepared by adsorbing the virus onto chick embryo red blood cells and subsequently eluting the virus . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Pediatric Department, St. Luke's Hospital, New York, and the Biological Laboratories, E. R. Squibb & Sons, New Brunswick, N. J.

Footnotes
Read before the American Public Health Association, Cleveland, Nov. 13, 1946, and the American Therapeutic Society, Atlantic City, N. J., June 7, 1947.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?